Valuation Incyte Corporation

Stocks

Real-time Estimate Cboe BZX 17:54:40 10/09/2026 +04			5-day change	1st Jan Change
126.14 ^USD	+0.10%		-2.12%	+26.85%

09-09	Incyte Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 11:00 AM
09-01	Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,213	17,869	14,072	13,306	19,391	25,542	-	-
Change	-	10.21%	-21.25%	-5.44%	45.73%	31.72%	-	-
Enterprise Value (EV) ¹	13,865	14,630	10,416	11,148	16,293	21,312	19,551	17,572
Change	-	5.52%	-28.81%	7.03%	46.15%	30.81%	-8.26%	-10.12%
P/E	17.2x	52.8x	23.7x	460x	15.4x	56.2x	17.4x	16x
PBR	4.32x	4.09x	2.71x	3.88x	3.79x	4.3x	3.25x	2.56x
PEG	-	-0.8x	0.3x	-4.9x	0x	-0.9x	0x	1.87x
Capitalization / Revenue	5.43x	5.26x	3.81x	3.14x	3.77x	4.3x	4.08x	3.89x
EV / Revenue	4.64x	4.31x	2.82x	2.63x	3.17x	3.59x	3.12x	2.68x
EV / EBITDA	21.5x	24.5x	14.8x	22.2x	9.53x	27.8x	9.19x	8.8x
EV / EBIT	23.7x	25.2x	16.8x	26.9x	10.1x	24.7x	8.59x	6.92x
EV / FCF	24.4x	16.4x	22.4x	44.8x	-	31.5x	12x	10x
FCF Yield	4.1%	6.1%	4.45%	2.23%	-	3.17%	8.35%	9.96%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.27	1.52	2.65	0.15	6.41	2.241	7.239	7.859
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,986	3,395	3,696	4,241	5,141	5,942	6,265	6,566
EBITDA ¹	643.6	597.7	703.2	503.1	1,709	766.9	2,126	1,996
EBIT ¹	585.8	579.4	620.5	413.9	1,616	863.9	2,276	2,540
Net income ¹	948.6	340.7	597.6	32.62	1,287	465.8	1,496	1,696
Net Debt ¹	-2,348	-3,239	-3,656	-2,158	-3,098	-4,230	-5,991	-7,970
Reference price ²	73.40	80.32	62.79	69.07	98.77	126.01	126.01	126.01
Nbr of stocks (in thousands)	220,891	222,475	224,109	192,650	196,323	202,698	-	-
Announcement Date	08/02/22	07/02/23	13/02/24	10/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INCYTE CORPORATION	56.23x	3.59x	27.79x	-.--%	25.54B
REGENERON PHARMACEUTICALS, INC.	18.7x	4.34x	10.2x	0.48%	80.65B
CSL LIMITED	20.24x	4.32x	13.42x	2.43%	59.12B
MODERNA, INC.	-16.13x	24.03x	-15.6x	-.--%	54.14B
SAMSUNG BIOLOGICS CO.,LTD.	35.37x	12.04x	23.09x	-.--%	50.1B
UCB	20.44x	4.52x	12.88x	0.71%	45.33B
BIOGEN INC.	36.39x	3.45x	13.17x	-.--%	31.14B
INNOVENT BIOLOGICS, INC.	65.36x	6.91x	42.04x	-.--%	21.8B
SWEDISH ORPHAN BIOVITRUM AB	23.23x	4.99x	12.99x	-.--%	16.06B
BRIDGEBIO PHARMA, INC.	-28.25x	15.63x	-42.03x	-.--%	14.87B
Average	23.16x	8.38x	9.79x	0.36%	39.88B
Weighted average by Cap.	21.26x	8.47x	10.36x	0.54%